메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
저널정보
한국임상약학회 한국임상약학회지 한국임상약학회지 제24권 제3호
발행연도
2014.1
수록면
219 - 228 (10page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

이 논문의 연구 히스토리 (2)

초록· 키워드

오류제보하기
Objectives: This paper was aimed to investigate the adhesion control standards of pain relieving patch (PRP) drugs andto survey it’s adverse effects on the skin of patients for safe use of PRP drugs. Methods: In this study, the related documentsof PRP drugs of Korea pharmacopoeia (KP), United States pharmacopoeia (USP), Japanese Pharmacopoeia (JP),European pharmacopoeia (EP), and information web sites of the Ministry of Food and Drug Safety (MFDS) were surveyed. Also, the past and current labeling of PRP drugs marketed in the pharmacy was investigated and compared. Results: In KP and JP, the lower limit standard for PRP's adhesion control is established, but the upper limit standardis not designated. In USP and EP, neither the lower nor upper limit standard is established. The main reasons of skinadverse effects are considered as inherent adverse reactions of the applied drugs for PRP. Another reason is involved inpatient's medication mistakes related to PRP's adhesion control, respiratory depression of skin according to physical skinclosure, and microbial growth, etc. Conclusion: For safe use of PRP drugs, we proposed ensured guidelines like additionalinstructions of pharmacist's prescription and detailed labeling systems for usage of PRP drugs applied on skin.

목차

등록된 정보가 없습니다.

참고문헌 (22)

참고문헌 신청

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0